Clinical Trial: To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07179484) titled 'To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma' on Aug. 28.

Brief Summary: To evaluate the efficacy of CT041 in sequential treatment after first-line treatment of advanced gastric/esophagogastric junction adenocarcinoma

Study Start Date: Sept. 22

Study Type: OBSERVATIONAL

Condition: Gastroesophageal Junction Adenocarcinoma

Intervention: DRUG: CT041 autologous CAR T-cell injection

The planned dose of CT041 is 2.5x108 cells. The participants are recommended to receive only a single infusion or multiple infusions (up to 3 infusions...